$13.36+0.06 (+0.45%)
Corteva, Inc.
Corteva, Inc. in the Basic Materials sector is trading at $13.36 with a market capitalization of $51.2B. Wall Street consensus targets $17.24 (11 analysts), implying a +29.1% move over the next 12 months. The stock is currently 9% below its 52-week high of $14.62, remaining 12.2% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | — | $4.91B↑ | $3.91B↑ | $2.62B↓ | $6.46B |
| Gross Profit | — | $2.53B↑ | $1.66B↑ | $974.00M↓ | $3.52B |
| Operating Income | — | $1.16B↑ | $242.00M↑ | -$270.00M↓ | $1.83B |
| Net Income | — | $720.00M↑ | -$552.00M↓ | -$320.00M↓ | $1.31B |
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait techno...
Academic risk and quality models computed from CTVA's own filings and price history, not from analyst opinion.
Strong on 7 of 9 fundamental-health tests covering profitability, leverage and operating efficiency.
Altman Z in the 1.81 to 2.99 grey zone, the band where the model gives no clear bankruptcy verdict.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
Hidden Markov model fitted to two years of returns, separating bull, bear and sideways states by their own drift and volatility.
GARCH(1,1) 30-day annualised forecast, below the current 39.6% reading.
Fama-French 5-factor market beta. The five factors explain 21% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-10-13.